Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea
· Delayed Price · Currency is KRW 86,600
-1,600 (-1.81%)
Last updated: Apr 29, 2026, 2:20 PM KST
KRX:185750 Revenue
In the year 2025, Chong Kun Dang Pharmaceutical had annual revenue of 1.69T KRW with 6.68% growth. Chong Kun Dang Pharmaceutical had revenue of 426.78B in the quarter ending December 31, 2025, with 2.75% growth.
Revenue
1,692.40B
Revenue Growth
+6.68%
P/S Ratio
0.69
Revenue / Employee
751.18M
Employees
2,253
Market Cap
1,162.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,692.40B | 105.97B | 6.68% |
| Dec 31, 2024 | 1,586.43B | -82.97B | -4.97% |
| Dec 31, 2023 | 1,669.40B | 181.06B | 12.17% |
| Dec 31, 2022 | 1,488.34B | 144.79B | 10.78% |
| Dec 31, 2021 | 1,343.56B | 40.55B | 3.11% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DongKook Pharmaceutical | 926.88B |
| Daewoong | 2,068.37B |
| Ildong Pharmaceutical | 566.93B |
| Boryung | 1,017.43B |
| GC Biopharma | 1,991.28B |
| Huons Global | 847.45B |
| Daewoong Pharmaceutical | 1,570.89B |
| JW Pharmaceutical | 775.30B |